Synthesis and preliminary PET study of the 5-HT7 receptor antagonist [11C]DR4446
Autor: | Jun Maeda, Kazutoshi Suzuki, Tetsuya Suhara, Terushi Haradahira, Takayo Kida, Ming-Rong Zhang, Takashi Okauchi, Shigeru Obayashi |
---|---|
Rok vydání: | 2002 |
Předmět: | |
Zdroj: | Journal of Labelled Compounds and Radiopharmaceuticals. 45:857-866 |
ISSN: | 1099-1344 0362-4803 |
DOI: | 10.1002/jlcr.606 |
Popis: | DR4446 (1-methyl-2a-[4-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)butyl]-2a,3,4,5-tetrahydro-1H-benz[cd]indole-2-one) is a potent 5-HT7 receptor antagonist (Ki=9.7 nM) with a high selectivity over other 5-HT family receptors (Ki for 5-HT1A: 770 nM; for other 5-HT receptors: >1000 nM). As a positron emission tomography (PET) tracer for the 5-HT7 receptor, [11C]DR4446 was synthesized at high radiochemical purity ( >98%) with specific activity of 73–120 GBq/μmol at the end of synthesis by the alkylation of the desmethyl precursor (1) with [11C]CH3I in the presence of NaH. A PET study in monkey demonstrated that [11C]DR4446 had good permeability into the brain, and had a specific binding component in the brain regions including the thalamus, possibly an area in the 5-HT7 receptors. Metabolite analysis showed that [11C]DR4446 was relatively stable and low percentages of two radio-labeled metabolites were detected in the plasma of monkey using HPLC. Copyright © 2002 John Wiley & Sons, Ltd. |
Databáze: | OpenAIRE |
Externí odkaz: |